Wordt geladen...
Treatment of high-risk neuroblastoma
Although high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT) have improved the prognosis for patients with high-risk neuroblastoma (NB), event-free survival rates remain in the range of 30 to 40%, which is unsatisfactory. To further improve outcomes, several clinical trial...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Pediatric Society
2012-04-01
|
| Reeks: | Korean Journal of Pediatrics |
| Onderwerpen: | |
| Online toegang: | http://kjp.or.kr/upload/pdf/kjped-55-115.pdf |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|